GeneDx Holdings Corp
WGS
View Detailed Chart
130.060USD
+2.060+1.61%
Close 12/31, 16:00（ET）Quotes delayed by 15 min
3.76BMarket Cap
1198.49P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.61%
5 Days
-4.43%
1 Month
-22.10%
6 Months
+40.89%
Year to Date
0.00%
1 Year
+69.22%
View Detailed Chart
TradingKey Stock Score of GeneDx Holdings Corp
Currency: USD Updated: 2025-12-31Key Insights
GeneDx Holdings Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 33/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 160.89.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
GeneDx Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
9
analysts
Buy
Current Rating
160.889
Target Price
+0.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
GeneDx Holdings Corp Highlights
StrengthsRisks
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 30.15% year-on-year.
Overvalued
The company’s latest PE is 1198.49, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 32.52M shares, decreasing 2.75% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 103.20K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.10.
GeneDx Holdings Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
GeneDx Holdings Corp Info
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Ticker SymbolWGS
CompanyGeneDx Holdings Corp
CEOStueland (Katherine A)
Websitehttps://sema4.com/
FAQs
What is the current price of GeneDx Holdings Corp (WGS)?
The current price of GeneDx Holdings Corp (WGS) is 130.060.
What is the symbol of GeneDx Holdings Corp?
The ticker symbol of GeneDx Holdings Corp is WGS.
What is the 52-week high of GeneDx Holdings Corp?
The 52-week high of GeneDx Holdings Corp is 170.870.
What is the 52-week low of GeneDx Holdings Corp?
The 52-week low of GeneDx Holdings Corp is 55.170.
What is the market capitalization of GeneDx Holdings Corp?
The market capitalization of GeneDx Holdings Corp is 3.76B.
What is the net income of GeneDx Holdings Corp?
The net income of GeneDx Holdings Corp is -52.29M.
Is GeneDx Holdings Corp (WGS) currently rated as Buy, Hold, or Sell?
According to analysts, GeneDx Holdings Corp (WGS) has an overall rating of Buy, with a price target of 160.889.
What is the Earnings Per Share (EPS TTM) of GeneDx Holdings Corp (WGS)?
The Earnings Per Share (EPS TTM) of GeneDx Holdings Corp (WGS) is 0.109.
Related Instruments
-0.58%
-0.40%
-0.67%
-1.09%
-0.74%
-0.67%
-0.73%
-0.59%
-1.38%
-0.62%
+0.48%
-0.50%
-0.66%
-0.78%
-0.85%
-1.11%
-0.63%
-1.10%
-1.57%
-0.65%
